HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eleonora Aronica Selected Research

Dermatomyositis (Dermatopolymyositis)

4/2022Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
5/2018Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis.
3/2015Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eleonora Aronica Research Topics

Disease

98Epilepsy (Aura)
03/2024 - 07/2002
68Seizures (Absence Seizure)
03/2024 - 07/2002
66Tuberous Sclerosis (Bourneville's Disease)
05/2024 - 10/2004
36Temporal Lobe Epilepsy
03/2024 - 07/2002
33Neoplasms (Cancer)
03/2024 - 06/2002
31Status Epilepticus (Complex Partial Status Epilepticus)
01/2023 - 01/2002
28Focal Cortical Dysplasia
04/2024 - 06/2003
25Inflammation (Inflammations)
01/2023 - 01/2008
19Glioma (Gliomas)
03/2024 - 05/2003
18Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2023 - 05/2003
16Astrocytoma (Pilocytic Astrocytoma)
04/2024 - 01/2011
13Inborn Genetic Diseases (Disease, Hereditary)
02/2024 - 07/2015
13Malformations of Cortical Development
01/2022 - 05/2003
12Alzheimer Disease (Alzheimer's Disease)
01/2024 - 10/2006
12Drug Resistant Epilepsy
01/2022 - 09/2003
11Glioblastoma (Glioblastoma Multiforme)
03/2024 - 05/2003
10Brain Diseases (Brain Disorder)
03/2024 - 01/2013
9Ganglioglioma
12/2022 - 09/2003
8Autistic Disorder (Autism)
02/2024 - 05/2012
8Intellectual Disability (Idiocy)
02/2024 - 03/2016
8Autism Spectrum Disorder
10/2023 - 01/2016
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 09/2005
8Disease Progression
10/2022 - 01/2014
8Encephalitis (Encephalitis, Rasmussen)
01/2019 - 05/2003
7Brain Neoplasms (Brain Tumor)
01/2023 - 03/2010
7Neuroinflammatory Diseases
10/2022 - 11/2018
7Hippocampal Sclerosis
10/2021 - 05/2004
6Muscular Diseases (Myopathy)
01/2024 - 03/2015
6Myositis (Idiopathic Inflammatory Myopathies)
01/2023 - 03/2015
6Gliosis
08/2022 - 05/2003
5Brain Injuries (Brain Injury)
02/2023 - 03/2005
5Hemimegalencephaly
01/2019 - 12/2004
4Parkinson Disease (Parkinson's Disease)
02/2023 - 01/2019
4Neurodevelopmental Disorders
10/2021 - 06/2007
3Traumatic Brain Injuries (Traumatic Brain Injury)
02/2023 - 01/2020
3Nervous System Diseases (Neurological Disorders)
08/2022 - 01/2012
3Dermatomyositis (Dermatopolymyositis)
04/2022 - 03/2015
3Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
01/2022 - 05/2017
3Infections
01/2022 - 04/2008
3Epileptic Syndromes
01/2021 - 07/2002
3Carcinogenesis
01/2020 - 12/2012
3Breast Neoplasms (Breast Cancer)
01/2020 - 06/2005
3Partial Epilepsies (Epilepsy, Partial)
01/2018 - 01/2014
3Medulloblastoma
08/2012 - 08/2006

Drug/Important Bio-Agent (IBA)

58trans-sodium crocetinate (crocetin)IBA
05/2024 - 10/2004
55Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2002
20TOR Serine-Threonine KinasesIBA
04/2024 - 01/2011
18MicroRNAs (MicroRNA)IBA
02/2023 - 01/2012
17Biomarkers (Surrogate Marker)IBA
01/2024 - 08/2010
15Anticonvulsants (Antiepileptic Drugs)IBA
01/2021 - 07/2002
12Kainic Acid (Kainate)IBA
10/2021 - 07/2002
11Messenger RNA (mRNA)IBA
01/2023 - 07/2002
11CytokinesIBA
10/2022 - 01/2008
10Sirolimus (Rapamycin)FDA Link
11/2022 - 07/2012
9gamma-Aminobutyric Acid (GABA)IBA
03/2024 - 12/2007
9Mechanistic Target of Rapamycin Complex 1IBA
01/2022 - 01/2013
8EverolimusFDA Link
04/2024 - 05/2012
8VigabatrinFDA Link
11/2023 - 09/2018
8RNA (Ribonucleic Acid)IBA
02/2023 - 10/2006
7EnzymesIBA
10/2022 - 01/2012
7InterleukinsIBA
01/2022 - 03/2005
7Adenosine (Adenocard)FDA LinkGeneric
01/2018 - 09/2009
6Amyloid (Amyloid Fibrils)IBA
01/2024 - 07/2013
6HMGB1 Protein (HMG1)IBA
01/2022 - 04/2010
6Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2020 - 07/2002
5RNA-Binding Proteins (RNA-Binding Protein)IBA
10/2023 - 09/2013
5mitomycin C-dextranIBA
10/2021 - 09/2009
5AntibodiesIBA
01/2020 - 09/2007
5Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2019 - 06/2003
5Glutamic Acid (Glutamate)FDA Link
06/2014 - 08/2006
4Therapeutic UsesIBA
03/2024 - 01/2016
4Matrix Metalloproteinases (MMPs)IBA
08/2022 - 07/2018
4Toll-Like Receptor 4IBA
01/2022 - 04/2010
4Amino Acid Transport System X-AG (Glutamate Transporter)IBA
03/2021 - 01/2002
4AlbuminsIBA
11/2020 - 12/2013
4Interleukin-6 (Interleukin 6)IBA
01/2018 - 04/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2016 - 06/2008
3CalciumIBA
02/2024 - 10/2004
3CannabidiolIBA
11/2023 - 11/2018
3ChemokinesIBA
08/2023 - 12/2020
3Matrix Metalloproteinase InhibitorsIBA
08/2022 - 07/2018
3Ligases (Synthetase)IBA
04/2022 - 03/2015
3CurcuminIBA
01/2022 - 01/2016
3Complement System Proteins (Complement)IBA
01/2022 - 09/2014
3AutoantibodiesIBA
12/2021 - 03/2015
3IronIBA
10/2021 - 09/2005
3Eosine Yellowish-(YS) (Eosin)IBA
01/2020 - 05/2010
3Protein Isoforms (Isoforms)IBA
01/2020 - 07/2004
3Hematoxylin (Haematoxylon)IBA
01/2020 - 05/2010
3Adenosine KinaseIBA
01/2020 - 07/2011
3AMPA Receptors (AMPA Receptor)IBA
01/2020 - 06/2009
3Carrier Proteins (Binding Protein)IBA
01/2019 - 07/2014
3Toll-Like Receptors (Toll-Like Receptor)IBA
03/2017 - 04/2011
3ParaffinIBA
09/2014 - 05/2010
3Receptor for Advanced Glycation End ProductsIBA
10/2013 - 04/2011
3Phenytoin (Dilantin)FDA LinkGeneric
02/2010 - 07/2002
3major vault proteinIBA
12/2004 - 09/2003

Therapy/Procedure

31Therapeutics
04/2024 - 04/2012
4Radiotherapy
01/2023 - 09/2007
4Drug Therapy (Chemotherapy)
01/2021 - 09/2011